1.68
1.68 (-1.37%)
As of Mar 06, 2024
Precigen, Inc. [PGEN]
Source:
Company Overview
Precigen, Inc. operates as a biopharmaceutical company. The Company develops gene and cell therapies to target the diseases in immuno-oncology, autoimmune disorders, and infections. Precigen serves customers worldwide.
Country | United States |
Headquarters | germantown, maryland |
Phone Number | 301-556-9900 |
Industry | manufacturing |
CEO | Helen Sabzevari |
Website | www.precigen.com |